This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.
Activity Details
18 * ! | Sun, 8/1/2010, 2:00 PM - 3:50 PM | CC-110 (West) |
Bayesian and Adaptive Design Applications in Early Phase Clinical Trials — Topic Contributed Papers | ||
Biopharmaceutical Section , ENAR , Section on Bayesian Statistical Science , Statistical Programmers and Analysts | ||
Organizer(s): Yuehui Wu, GlaxoSmithKline | ||
Chair(s): Bingming Yi, GlaxoSmithKline | ||
2:05 PM | Novel Phase I Design for Oncology Research — Linda Sun, Merck & Co., Inc. ; Keaven M. Anderson, Merck Research Laboratories ; Lisa Lupinacci, Merck & Co., Inc. ; Yevgen Tymofyeyev, Merck & Co., Inc. | |
2:25 PM | Better Learning About the MTD in Phase I Oncology Trial: A Case Study Implementing Bayesian Design Based on Continuous Reassessment Method — Inna Perevozskaya, Pfizer Inc. | |
2:45 PM | Adaptive Designs in Dose-Finding Oncology Drug Combination Trials — Yuehui Wu, GlaxoSmithKline ; Bingming Yi, GlaxoSmithKline ; Yanmei Xu, GlaxoSmithKline | |
3:05 PM | Evaluation of Dose-Finding Designs: On the Interplay Between Theory and Simulation — Assaf P. Oron, University of Washington ; Peter Hoff, University of Washington | |
3:25 PM | Expect the Unexpected: Bayesian Adaptive Dose-Finding Design in Proof-of-Concept Study — Feng Liu, GlaxoSmithKline | |
3:45 PM | Floor Discussion |
2010 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.